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Nasopharyngeal carcinoma (NPC) is a cancer that arises inside of the nasopharyngeal mucosa and 
nasopharynx. Epstein Barr Virus (EBV) has been shown to be associated with the development of 
NPC. Latent Membrane Protein 1 (LMP1) function include to activate BamHI-Z Leftward Reading 
Frame 1 (BZLF1)-EBV. The infection tissues respond to the expansion of EBV infection by activating 
Poly(ADP-ribose)Polymerase-1 (PARP1). The objective of this study are to observe the expression of 
BZLF1 and to determine the PARP1 regulation in NPC tissues. This study used three kind of tissue 
slides, there are non-keratinizing carcinoma, undifferentiated carcinoma, and polyp. Tissue slides were 
stained by HE used for characterization of the necrotic cells such as pyknosis cells, karyorrhexsis cells, 
and karyolysis cells. Tissues slides were analyzed by immunohistochemical (IHC) assays using EBV 
BZLF1-FITC and anti-PARP1-Rhod. The percentage of necrotic cells and the expression intensity  of 
BZLF1 and PARP1 were analyzed using statistical analysis (P-value < 0.05). This study also used 
correlation and regression analysis. The research showed that the number of karryorhexis cells higher 
than pyknosis cells and karyolysis cells in NPC and polyp tissues. The high expression intensity of 
BZLF1 induced the increase of expression intensity of PARP1, and the expression intensity of BZLF1 
and PARP1 are not correlated with percentage of necrotic cell. Interestingly, all tissues showed the 
increased number of karyolysis cells but the number of pyknosis cells and karryorrhexis cells were 
remain low. The intensity of expression indicated that the BZLF1 induce PARP1 to repair DNA 
damage against EBV infection. 
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INTRODUCTION 
NPC is a cancer that arises in the epithelial 
tissues that covers lining of surface, inner 
mucosa and crypts of nasopharynx. Features of 
cancer were included rapid growth of cells, in-
creased cell turn-over, invasive growth, metas-
tasis, vascular or lymphatic channel invasion 
for malignant lesions [1-2]. EBV is a human 
herpesvirus, and be a mayor risk for NPC. 
Most cells and blood of patients have a part of 
EBV. All herpes viruses have two phases life 
cycle, involved latency and lytic (reactivation or 
replication) phase.  
EBV in a latent infection is associated with 
the expression  of nine latent proteins.  Latent  
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membrane   Protein  1  (LMP1)  is  one  of  the 
latent proteins, and major EBV oncoprotein. 
This protein functions include for metastasis, 
apoptotic resistance, immune modulation and 
toactivate BamHI-Z Leftward Reading Frame 1 
(BZLF1)-EBV, which can inhibit p53 to induce 
apoptotic resistance, metastasis, and immune 
modulation. BZLF1 is one of  immediate-early 
(IE) transcription factors, that are responsible 
for the expression of packing proteins of EBV. 
BZLF-EBV functions to induce lytic infection 
in EBV infected cell [3-4].  
The infection tissues respond to the 
expansion of EBV infection by activating Poly 
(ADP-ribose) Polymerase-1 (PARP1). The syn-
thesis of PARP1 is one of the early DNA da-
mage responses, together with other DNA 
sensing molecules, such as DNA-PK, ATM and 
p53 [5]. Over expression of PARP1 estimated 
from EBV-DNA integrated with host-DNA 
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and this may induce a decrease in NAD+ and 
ATP levels which promotes cell dysfunction 
and cell death by necrosis [6].  
Correlation among PARP1, BZLF1-EBV, 
and necrotic percentage in NPC tissue are still 
unclear. The objective of this study is to ob-
serve the expression of BZLF1 and determine 
the PARP1 regulation in nasopharyngeal carci-
nomas tissues. 
 
MATERIALS AND METHODS 
Three kinds of histopathological tissue 
slides, non-keratinize carcinoma, undifferen-
tiated carcinoma, and polyp was used in this 
study. All of these tissues slides were collected 
from Ulin Hospital, Banjarmasin, South Kali-
mantan. NPC tissues were obtained from biop-
sy which was done for early prediction of NPC 
patients. Methods and protocol of this study 
was approved by the Ethical Research Com-
mission of Brawijaya University (Indonesia). 
The number of necrotic cells and the 
expression intensity of BZLF1 and PARP1 of 
each histopathological tissue slides were obser-
ved. This study used two kind of staining 
methods, hematoxylin eosin (HE) and immu-
nohistochemical (IHC) assays. HE staining was 
conducted at Ulin Hospital, South Kalimantan. 
Histological slides were stained by HE used for 
characterization of the necrotic cells such as 
pyknosis (nuclear shrinkage) cells, karyorrhex-
sis (nuclear fragmentation) cells, and karyolysis 
(nuclear fading) cells. The necrotic cells obser-
ved using a BX-53 microscope (Olympus) with 
CellSens Standard software at the Biosains 
Laboratory, Brawijaya University, Malang.  
 Tissues slides were analyzed by IHC, 
modified from [7] by using EBV-BZLF1 
Mouse anti-EBV monoclonal antibody (Life-
span Biosciences) (1:1000) against Goat anti-
mouse IgG-FITC (Santa Cruz Biotechnology) 
(1:1500) and anti-PARP1 antibody (MC-10) 
(1:1500) against Goat anti-mouse IgG labeled 
Rhodamin (Santa Cruz Biotechnology)(1:1500). 
The expression intensity of BZLF1 and 
PARP1 from fluorescent colour was observed 
by Confocal Laser Scanning Microscope 
(Olympus) with Olympus FluoView software 
version 1.7α at the Central Laboratory of Life 
Sciences (LSIH). Visualization of expression of 
BZLF1 and PARP1 was performed on three 
fields of view of each slide. Measurement of 
the expression intensity of each field of view is 
taken from 5 points. Observations and 
measurements take on the location of the 
expression of BZLF1 and PARP1. 
The percentage of necrotic cells and 
expression intensity of BZLF1 and PARP1 
were analyzed using SPSS 16.0 by one-way 
ANOVA test (P-value < 0.05). This study used 
correlation analysis to test the statistical 
significance of association between variables, 
and regression analysis to identify the effect of 
each variable. 
 
RESULTS AND DISCUSSION 
The result of this study showed that 
karyorrhexsis cells more commonly found than 
pyknosis cells and karyolysis cells. All tissues 
(non keratinize carcinoma, undifferentiated 
carcinoma, and polyp) showed the increased 
number of karyolysis cells, but the number of 
pyknosis cells and karryorrhexis cells were 
remain low (Fig. 1). 
The high percentage of karyorrhexsis cells 
in all tissues indicates that the nucleus was 
damage and PARP1 failed to repair damaged 
cells, therefore the tissue target has a me-
chanism of cell death by necrosis.  
This result was similar with previous 
research by Cepeda et al. [6] which states that 
DNA damage will cause a very large excess of 
PARP1 expression, this may induce a decrease 
in NAD+ and ATP levels which lead to cell 
dysfunction and even cause cell death by 
necrosis. 
The results of this study showed that the 
expression intensity of BZLF1 and PARP1 in 
polyp tissue tends to be lower than the non 
keratinize carcinoma, undifferentiated carci-
noma. The expression intensity of BZLF1 and 
PARP1 at polyp tissue were remain low (Fig. 2 
(supplement 1)). Nevertheless, the results of 
statistical analysis showed that the intensity of 
expression of BZLF1 and PARP1 was not 
significantly different in polyp, non keratinize 
carcinoma and undifferentiated carcinoma. The 
high intensity of expression of BZLF1-NPC 
showed that the infection has reached the stage 
of EBV lytic phase. 
BZLF1 is a protein that plays a role in the lytic 
phase of EBV [3]. When the initially of EBV 
infection, LMP1 has been started to enable 
exposure to BZLF1. In addition, over ex-
pression  of  BZLF1  in EBV-infected cells is 
sufficient to initiate the conversion of latent 
infection to lytic / productive infection [8]. 
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Figure 1. The percentages of necrotic cells (pyknosis cells, karyorrhexsis cells, and karyolysis cells) (A), and the result of 
regression analysis of karyolysis cells (B). 
 
BZLF1 is a transcription factor immediate-
early (IE) than BRLF1, which is responsible for 
the expression of proteins required in the form 
capable of infecting virus [4]. Although BZLF1 
was essentially required in the replication of 
oriLyt, a mechanism is also assisted by another 
protein, BMRF1 are required in the viral 
polymerase [8]. On polyp tissue the levels of 
EBV infection were low, presumably because it 
has not reached the stage of EBV lytic 
infection, the expression intensity of BZLF1 in 
polyp is lower than in NPC. Gelardi [9] found 
that the nasal polyp is a benign tumor, while 
NPC is malignant tumors. 
 The higher value of expression intensity in 
PARP1-NPC than PARP1 in polyps was due to 
infection of EBV in NPC conditions will acti-
vate PARP1 which is protection of cells against 
DNA damage. PARP1 is involved in initiation 
of DNA damage response mechanisms, inclu-
ding DNA repair, cell cycle arrest and apoptosis 
[10].  
A number of PARP1 inductions are included 
gamma radiation, TNFα, alkylating agents, 
UVB, and free radicals. After the cells exposed 
to induction agents of PARP1, the PARP1 will 
bound directly to DNA damage and have auto 
modification thus forming polymer poly (ADP-
Ribose) long, branched at the target protein, 
using the substrate NAD+, which affects the 
depletion of NAD+ intracellular [11].  
PARP1 is the first cellular protein identified 
in the mechanism of apoptosis [5]. Activation of 
caspase-3 (ACA-3) break down proteins, inclu-
ding poly (ADP Ribose) polymerase-1 (PARP1) 
is important in DNA repair, causing by apop-
tosis. Over activation of PARP1 led to deplet-
ion of NAD+ and ATP, and causing necrosis 
[11]. 
The severity of disease in polyp is lower than 
in the NPC. It was shown that the expression 
intensity of PARP1 in polyp lower than in NPC. 
The expression intensity of BZLF1 tends to be 
lower than PARP1. This condition occurred  
because in the normal condition PARP1 were 
synthesized even in small amounts, whereas 
BZLF1 will be expressed when the infection of 
EBV reaches to the lytic stage.  
PARP1 is responsible for post-translational 
modification of proteins in response to many 
endogenous and environmental genotoxic 
agents. PARP and poly (ADP-ribosyl)ation to 
be something important in the regulation of 
many cellular processes such as DNA repair, 




The result of this study showed that the 
highest number of necrotic cells was 
karryorhexsis cells in all tissues. Interestingly, all 
tissues (non keratinize carcinoma, undifferentia-
ted carcinoma, and polyp) showed that the 
increased number of karyolysis cells, but the 
number of pyknosis cells and karryorrhexis cells 
were remain low. The high expression intensity 
of BZLF1 induced the increasing of expression 
intensity of PARP1, but not correlated with 
percentage of necrotic cell. The intensity of 
expression indicated that the BZLF1 induce 
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Supplement 1 
 
Figure 2. Hematoxylin-eosin–stained slides (A for NPC and B for polyp). IHC result of BZLF1 (C and D), PARP1 (E 
and F), merge (G and H) (magnification 400x). Regression of BZLF1 (I) and PARP1 (J). The expression 
intensity of BZLF1 (K) and PARP1 (L) in polyp, non-keratinize carcinoma, and undifferentiated carcinoma
 
